Clinical Trial Update: A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II trial evaluating belotecan in combination with ifosfamide for extensive-disease small cell lung cancer; the study status is not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Belotecan (Belotecan)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN